TGFB1 and neoplasm: The rfhSP-D treatment of these cell lines for up to 24 h prevented their morphological alterations associated with EMT, reduced tumor cell invasion in the matrigel, downregulated TGF-β production, and downregulated key mesenchymal gene expression, such as Vimentin, Zeb1, and Snail.